Boston Scientific Corporation (0HOY.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 141.93B |
| Enterprise Value | 152.3B |
| P/E Ratio | 18.47 |
| PEG Ratio | 0.25 |
| Price/Sales Ratio | 3.2 |
| Price/Book Ratio | 2.55 |
| Enterprise/Revenue | 3.66 |
| Enterprise/EBITDA | 13.32 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 20.07B |
| Revenue/Share | 13.88 |
| Gross Profit | 13.06B |
| EBITDA | 5.44B |
| Net Income | 2.89B |
| Diluted EPS | 1.94 |
Balance Sheet
| Total Cash | 1.52B |
| Total Cash/Share | 1.03 |
| Total Debt | 11.03B |
| Total Debt/Equity | 0.43 |
| Current Ratio | 1.9 |
| Book Value Per Share | 17.58 |
Price History
| 52-Week Change | -56.44 |
| 52-Week High | 68 |
| 52-Week Low | 44.08 |
| Moving Average 50 Days | 63.51 |
| Moving Average 200 Days | 55.52 |
Statistics
| Average Volume | 26,833 |
| Shares Outstanding | 1.49B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
